Y-Intercept (HK)’s MacroGenics MGNX Stock Holding History

Y-Intercept (HK)’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29,945	Closed	-$36.2K	–	1850
2025 Q2	$36.2K	Buy	+29,945	New	+$43.4K	﹤0.01%	1573
2024 Q3	–	Sell	-12,325	Closed	-$52.4K	–	1601
2024 Q2	$52.4K	Buy	+12,325	New	+$120K	﹤0.01%	1301
2021 Q2	–	Sell	-7,938	Closed	-$247K	–	786
2021 Q1	$247K	Buy	+7,938	New	+$193K	0.07%	481

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Y-Intercept (HK)'s MGNX Position: Q3 2025 in Review

Y-Intercept (HK) sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 29,945 shares — an estimated $36.2K sold.

Y-Intercept (HK) first reported a position in MGNX in Q1 2021 and held it in 3 quarters. The position peaked at $247K in Q1 2021. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

Y-Intercept (HK) reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
Y-Intercept (HK) sold 29,945 MacroGenics shares in Q3 2025, an estimated $36.2K.
Y-Intercept (HK) first reported a position in MacroGenics in Q1 2021 and held it in 3 quarters.
Y-Intercept (HK)'s MacroGenics position peaked at $247K in Q1 2021.
104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.